TUNGKOL SA EPISODE NA ITO
As managing director of BioRN, Dr. Julia Schaft sits at the center of one of Europe's most powerful biotech ecosystems — connecting world-class research institutions, startups, and 9 of the top 20 global pharma companies within the Heidelberg region. In this episode, she unpacks why Europe keeps losing biotech companies to the US, how Germany's risk-averse culture holds back innovation, and what it actually takes to turn academic science into real products.
Dr. Julia Schaft is the Managing Director of BioRN, the biotech cluster covering Heidelberg and the broader Rhein-Neckar region. She holds a PhD from EMBL and has spent over a decade building bridges between academia, industry, and policy to strengthen Germany's life science ecosystem.
📥 We distilled the sharpest lessons from our first 6 guests into one free guide — the Insider Biotech Career Starter Pack. Get it at https://transcribedpod.com
Julia explains:◼️ Why Europe has dropped from #2–3 to #7–8 globally in clinical trials — and how bureaucracy and slow processes are driving startups to the US◼️ The "valley of death" problem: German startups get funded at the seed stage but struggle to find capital for preclinical development◼️ Why "Americans tend to overpromise and Europeans tend to undersell" — and what that means for European science◼️ Her honest take on AI in life sciences: "The ultimate proof that it's actually really working is still out there"◼️ How BioRN grew from 70–80 members to 185 by creating genuine win-win collaborations instead of funding-driven alliances
00:00 Welcome to Transcribed00:44 What Is BioRN? How a Biotech Cluster Works01:40 A Day in the Life of a Managing Director03:58 What Startups, Pharma, and Academia Need from BioRN05:20 From Lab Bench to Ecosystem Builder: Julia's Career Shift06:55 What Makes Heidelberg a Top European Biotech Hub08:35 The Biggest Obstacles to Translating Science into Products11:00 Is Europe Falling Behind the US and China?13:00 Venture Capital and Risk Culture: Europe vs. America15:40 How to Get Competitors to Actually Collaborate17:20 Talent Retention: "We Don't Need to Attract Them — We Need to Keep Them"18:35 BioRN's Growth: From 80 Members to 18520:07 Scientist by Heart, Networker by Evolution21:18 AI in Life Sciences: Promise vs. Proof23:10 Advice for Young Scientists Considering Industry25:01 Will AI Take Away Jobs in Biotech?26:00 Closing
Follow Julia:LinkedIn - https://www.linkedin.com/in/julia-schaft-409396a/
---
Transcribed Podcast — in-person interviews with scientists, founders, and industry experts shaping the future of biotech and pharma.
🎙️ Watch all episodes: https://www.youtube.com/@TranscribedPod📥 Free Biotech Starter Pack → https://transcribedpod.com🌐 https://transcribedpod.com📸 Instagram: @transcribedpod📧 thetranscribedpod@gmail.com
🎵 Jingle composed by Tembeh → https://open.spotify.com/artist/4s9JmadJjVdYQ6YxYtJgja
#TranscribedPodcast #Biotech #Pharma #Science #Interview #BioRN #Heidelberg #Startups #VentureCapital #Innovation
